Group 1 - The Hong Kong Stock Connect Innovative Drug ETF (Southern, 159297) experienced a decline of 1.96% with a trading volume of 47.07 million yuan on December 29 [1] - The fund's shares increased by 5 million, bringing the total shares to 1.815 billion, with an increase of 186 million shares over the past 20 trading days [1] - The latest net asset value of the fund is calculated to be 1.455 billion yuan [1] Group 2 - The performance benchmark for the Hong Kong Stock Connect Innovative Drug ETF is the National Index for Hong Kong Stock Connect Innovative Drugs, adjusted for valuation exchange rates [1] - The fund is managed by Southern Fund Management Co., Ltd., with fund managers Zhang Qisi and Ye Zhenan [1] - Since its establishment on September 12, 2025, the fund has reported a return of -19.85%, with a one-month return of -10.93% [1]
12月29日港股通创新药ETF南方（159297）份额增加500.00万份
Xin Lang Cai Jing·2025-12-30 01:10